Please use this identifier to cite or link to this item:
https://doi.org/10.1371/journal.pone.0097555
Title: | Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model | Authors: | Ang M. Ng X. Wong C. Yan P. Chee S.-P. Venkatraman S.S. Wong T.T. |
Keywords: | polycaprolactone prednisolone acetate prednisolone prednisolone acetate animal cell animal experiment animal model animal tissue article biodegradable implant controlled study drug efficacy drug formulation drug implant drug release drug tolerability enucleation experimental uveitis eye inflammation histopathology in vitro study in vivo study male microfilm nonhuman rabbit randomized controlled trial recurrent disease scoring system analogs and derivatives animal chemistry conjunctiva drug administration route inflammation prostheses and orthoses surgery uveitis Animals Conjunctiva Drug Administration Routes Inflammation Male Prednisolone Prostheses and Implants Rabbits Uveitis |
Issue Date: | 2014 | Citation: | Ang M., Ng X., Wong C., Yan P., Chee S.-P., Venkatraman S.S., Wong T.T. (2014). Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model. PLoS ONE 9 (5) : e97555. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0097555 | Rights: | Attribution 4.0 International | Abstract: | Aim: To assess the efficacy of a biodegradable, prednisolone acetate implant in a rabbit uveitis model. Methods: Randomized, controlled study of biodegradable microfilms preloaded with prednisolone acetate (PA) in a rabbit uveitis model. Experimental uveitis was induced by unilateral intravitreal injection of Mycobacterium tuberculosis H37Ra antigen (50 ug; 1 ug/uL) in preimmunized rabbits. PA-loaded poly[d,l-lactide-co-?-caprolactone] (PLC) microfilms (n = 10) and blank microfilms (n = 6) were implanted subconjunctivally. An estimate of PA release in vivo was calculated from measured residual PA amounts in microfilms after the rabbits were sacrificed. The eyes were clinically monitored for ocular inflammation for 28 days. Histopathological examination of the enucleated eyes was performed at the end of the study period. Results: In vitro studies revealed that sandwich PA-loaded microfilm formulations exhibited higher release kinetic compared to homogenous PA-loaded microfilms. The 60-40-60% microfilm released an average of 0.034 mg/day of PA over the period of 60 days in vitro; and we found that approximately 0.12 mg/day PA was released in vivo. Animals implanted with the PA-loaded microfilms exhibited significantly lowered median inflammatory scores when compared against the control group in this model for recurrent uveitis (P<0.001). The implants were clinically well tolerated by all the animals. Histology results showed no significant scarring or inflammation around the PA-loaded microfilms. Conclusion: Our pilot study demonstrated that a subconjunctival PA-loaded implant is effective in suppressing inflammation in the rabbit model of uveitis, by providing therapeutic levels of PA that attenuated the inflammatory response even after a rechallenge. Longer term studies are now needed to establish the therapeutic potential of such a delivery system for treatment of ocular inflammation. © 2014 Ang et al. | Source Title: | PLoS ONE | URI: | https://scholarbank.nus.edu.sg/handle/10635/161411 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0097555 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1371_journal_pone_0097555.pdf | 1.13 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License